Conning Inc’s Moderna MRNA Stock Holding History

Conning Inc’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$351K	Buy	+1,821	New	+$196K	0.01%	252
2024 Q3	–	Sell	-2,121	Closed	-$252K	–	360
2024 Q2	$252K	Buy	2,121 +43	+2%	+$5.44K	0.01%	312
2024 Q1	$221K	Hold	2,078	–	–	0.01%	334
2023 Q4	$207K	Buy	+2,078	New	+$175K	0.01%	340
2023 Q2	–	Sell	-1,619	Closed	-$249K	–	371
2023 Q1	$249K	Sell	1,619 -28	-2%	-$4.62K	0.01%	324
2022 Q4	$296K	Sell	1,647 -792	-32%	-$129K	0.01%	308
2022 Q3	$288K	Sell	2,439 -174	-7%	-$26.4K	0.01%	298
2022 Q2	$373K	Sell	2,613 -27	-1%	-$3.86K	0.01%	279
2022 Q1	$455K	Sell	2,640 -440	-14%	-$74.1K	0.01%	272
2021 Q4	$782K	Buy	3,080 +80	+3%	+$23.4K	0.02%	205
2021 Q3	$1.16M	Buy	+3,000	New	+$1.11M	0.03%	187

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

Beau Ventures Pittsford, New York $1.06B AUM 83.06% 1-Year Est. Return

Conning Inc's MRNA Position: Q3 2026 in Review

Conning Inc opened a new position in Moderna (MRNA) in Q3 2026: 1,821 shares worth $351K. The stake represents 0.01% of the portfolio and ranks #252 among its holdings. This is a return to the name: Conning Inc previously reported a position in MRNA as recently as Q2 2024.

Conning Inc first reported a position in MRNA in Q3 2021 and has held it in 11 quarters since. The position peaked at $1.16M in Q3 2021. 633 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

Conning Inc held 1,821 shares of Moderna worth $351K as of Q3 2026.
Moderna was a new Conning Inc position in Q3 2026.
Moderna made up 0.01% of Conning Inc's portfolio in Q3 2026, its #252 holding.
Conning Inc first reported a position in Moderna in Q3 2021 and has held it in 11 quarters since.
Conning Inc's Moderna position peaked at $1.16M in Q3 2021.
633 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Conning Inc's 13F filing for Q3 2026, filed 27 Oct 2026.